The latest study released on the Global Cholera Vaccine Market by AMA Research evaluates market size, trend, and forecast to 2026. The Cholera Vaccine market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/3604-global-cholera-vaccine-market
Definition and Brief Information about Cholera Vaccine:
Cholera is a bacterial disease caused by the ingestion of food or water contaminated with the bacterium Vibrio cholerae, which can lead to dehydration and even death if untreated. According to the World Health Organization (WHO) each year there are 1.3 million to 4.0 million cases of cholera, and 21 000 to 143 000 deaths worldwide due to cholera. Cholera vaccine is a sterile suspension of equal parts of Ogawa and Inaba serotypes of killed Vibrio cholerae (V. comma) in buffered sodium chloride injection and that can be injected intracutaneously (intradermally), subcutaneously or intramuscularly. In January 2020, Emergent BioSolutions Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for the approval of the companyâ€™s single-dose oral cholera vaccine, Vaxchora (Cholera Vaccine, Live, Oral).
This Report also covers the emerging player’s data, including: competitive situation, sales, revenue and global market share of top manufacturers such as: PaxVax, Inc. (United Sates), Valneva SE (France), Emergent BioSolutions, Inc. (United States), Astellas Pharma, Inc. (Japan), Sanofi S.A. (France), Eubiologics Co., Ltd. (South Korea), Johnson & Johnson (United States), Celldex Therapeutics, Inc. (United States), Merck & Co., Inc. (United States), GlaxoSmithKline plc. (United Kingdom)
Keep yourself up-to-date with latest market trends and changing dynamics due to COVID Impact and Economic Slowdown globally. Maintain a competitive edge by sizing up with available business opportunity in Cholera Vaccine Market various segments and emerging territory.
Increased Research and Development Activities
Rising Government Initiatives for Development of Vaccines
Increasing Number of Cholera Patients Worldwide
Rise in the Hospitals and Clinics
Growing Healthcare Infrastructure in Emerging Economies
Growth in the Healthcare Industry Worldwide
Huge Investments by Major Players
Robust Increase in the Distribution Channels
Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/3604-global-cholera-vaccine-market
The Global Cholera Vaccine Market segments and Market Data Break Down are illuminated below:
by Type (Shanchol, Dukoral, Vaxchora, Others), End-users (Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others), Serogroup (Serogroup O1, Serogroup O139)
What benefits does AMA research study is going to provide?
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Strategic Points Covered in Table of Content of Global Cholera Vaccine Market:
Get More Information: https://www.advancemarketanalytics.com/reports/3604-global-cholera-vaccine-market
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
(*If you have any special requirements, please let us know and we will offer you the report as you want.)